INS and type 2 diabetes mellitus: Increasing the number of insulin-producing beta cells represents a promising therapeutic strategy that would improve the clinical outcome in both type 1 and type 2 diabetes patients by enhancing insulin secretion, improving glucose homeostasis and reducing the risk of secondary complications.